文献速递瓣膜病与结构性心脏病

严重钙化二叶式与三叶式主动脉瓣狭窄TAVR结局对比

Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification.
PubMed 文献 · Heart · 2025-11-25

基于中国心血管健康联盟数据库-国家经导管瓣膜治疗注册研究,分析870对倾向评分匹配的严重钙化(≥470 mm³)主动脉瓣狭窄患者,比较二叶式与三叶式TAVR的安全性和有效性。1年全因死亡率无显著差异(4.3% vs 5.3%,HR 0.87;log-rank p=0.62),二叶式组新发永久起搏器植入率更高(8.4% vs 5.6%;p=0.03)。

要点

  • 严重钙化二叶式与三叶式AS患者TAVR术后1年全因死亡率无显著差异。
  • 二叶式AS患者新发永久起搏器植入率显著高于三叶式(8.4% vs 5.6%;p=0.03)。
  • 技术成功、卒中、心血管住院及中重度瓣周漏发生率两组相似。

核心结论

  • 在严重钙化主动脉瓣狭窄患者中,TAVR对二叶式与三叶式AS表现出同等的安全性和有效性。
  • 二叶式AS与更高的永久起搏器植入率相关。

研究设计与样本

  • 基于中国心血管健康联盟数据库-国家经导管瓣膜治疗注册研究的倾向评分匹配分析。
  • 纳入2014年4月至2023年8月接受TAVR的严重钙化(≥470 mm³)患者,共870对匹配对。
  • 主要结局为1年全因死亡率。

主要发现

  • 技术成功率二叶式95.1% vs 三叶式94.7%,无显著差异。
  • 1年全因死亡率二叶式4.3% vs 三叶式5.3%(HR 0.87;log-rank p=0.62)。
  • 随访期间卒中(1.5% vs 1.4%)、心血管住院(1.4% vs 1.7%)及中重度瓣周漏(3.5% vs 2.5%)发生率相似。
  • 新发永久起搏器植入率二叶式8.4% vs 三叶式5.6%(p=0.03)。

关键数值与推荐

  • 严重钙化定义为钙化体积≥470 mm³。
  • 主要结局为1年全因死亡率,二叶式4.3% vs 三叶式5.3%(HR 0.87;log-rank p=0.62)。
  • 新发永久起搏器植入率二叶式8.4% vs 三叶式5.6%(p=0.03)。

临床怎么用

  • 严重钙化二叶式AS患者行TAVR时,需关注永久起搏器植入风险。
  • TAVR在严重钙化二叶式与三叶式AS中均可考虑,短期安全性和有效性相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The comparative outcomes of transcatheter aortic valve replacement (TAVR) in bicuspid versus tricuspid aortic stenosis (AS) with severe calcification remain unclear. This study aimed to compare the safety and efficacy of TAVR in these patient groups. METHODS: Using data from the Chinese Cardiovascular Association Database-National Transcatheter Valve Therapeutics Registry, we analysed 870 propensity score matched pairs of patients with severe calcification (≥470 mm³) undergoing TAVR between April 2014 and August 2023. Primary outcome was all-cause mortality at 1 year. RESULTS: No significant differences were observed in technical success (95.1% vs 94.7%), procedural complications or in-hospital outcomes. All-cause mortality at 1 year was similar between bicuspid and tricuspid AS (4.3% vs 5.3%, HR 0.87; log-rank p=0.62). The incidence of stroke (1.5% vs 1.4%), cardiovascular hospitalisation (1.4% vs 1.7%) and moderate-to-severe paravalvular leak (3.5% vs 2.5%) was similar during follow-up. The rate of new permanent pacemaker implantation was higher in bicuspid AS (8.4% vs 5.6%; p=0.03). CONCLUSIONS: TAVR was observed to be equally safe and effective in bicuspid and tricuspid AS with severe calcification, though bicuspid AS was associated with a higher rate of permanent pacemaker implantation.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Sun Y, Wang C, Li J, et al. Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification. Heart. 2025. PMID: 40348412. doi:10.1136/heartjnl-2024-324697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。